09:18 AM EST - Bee Vectoring Technologies International : Announces an R&D agreement with Syensqo (2NF.F) (SYENS.BR) to develop its proprietary biological control agent Clonostachys rosea strain CR-7 into a seed treatment formulation for the multi-billion soybean market. “Collaborating with Syensqo is a huge extension of our R&D efforts,” said Ashish Malik, CEO of BVT. “Their large team of formulation chemists and microbiologists will enable us to get to market with a strong seed treatment formulation much faster.” Bee Vectoring Technologies International
shares C.BEE are trading unchanged at $0.01.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=BEE%3ACNX&qmodStoryID=8977343578738147
